Standardization of FSH, LH and hCG-Current position and future prospects

Molecular and Cellular Endocrinology

Volumn 260-262, Issue , 2007, Pages 301-309

  Sturgeon, C M ^a   Ellis, A R ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Chorionic gonadotropin; Follicle stimulating hormone; FSH; hCG; International Standards; LH; Luteinizing hormone; Method comparability; Standardization

Indexed keywords

CHORIONIC GONADOTROPIN; FOLLITROPIN; LUTEINIZING HORMONE;

ACCURACY; ANTIBODY SPECIFICITY; ARTICLE; CALIBRATION; FOLLITROPIN BLOOD LEVEL; GONADOTROPIN BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; NOMENCLATURE; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; STANDARDIZATION;

ANTIBODY SPECIFICITY; CALIBRATION; GONADOTROPINS; HUMANS; IMMUNOASSAY; QUALITY CONTROL; REFERENCE STANDARDS;

EID: 33751243637     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2006.09.004     Document Type: Article

References (32)

1. Bangham D.R., Berryman I., Burger H., Cotes P.M., Furnival B.E., Hunter W.M., Midgley A.R., Mussett M.V., Reichert Jr. L.H., Rosemberg R.J., Ryan R.J., and Wide L. An international collaborative study of 69/104, a reference preparation of human pituitary FSH and LH. J. Clin. Endocrinol. 36 (1973) 647-660
2. Berger P., Bidart J.M., Delves P.S., Dirnhofer S., Hoermann R., Isaacs N., Jackson A., Klonisch T., Lapthorn A., Lund T., Mann K., Roitt I., Schwarz S., and Wick G. Immunochemical mapping of gonadotropins. Mol. Cell. Endocrinol. 125 (1996) 33-43
3. Berger P., Sturgeon C., Bidart J.M., Paus E., Gerth R., Niang M., Bristow A., Birken S., and Stenman U.-H. The ISOBM TD-7 Workshop on hCG and related molecules. Towards user-oriented standardization of pregnancy and tumor diagnosis: Assignment of epitopes to the three-dimensional structure of diagnostically and commercially relevant monoclonal antibodies directed against human chorionic gonadotropin and derivatives. Tumor Biol. 37 (2002) 1-38
4. Birken S., Berger P., Bidart J.-M., Weber M., Bristow A., Norman R., Sturgeon C., and Stenman U.-H. Preparation and characterization of new WHO reference reagents for human chorionic gonadotropin (hCG) and metabolites. Clin. Chem. 49 (2003) 144-154
5. Bristow A., Berger P., Bidart J.-M., Birken S., Norman R., Stenman U.-H., and Sturgeon C.M. Establishment, value assignment, and characterization of new WHO reference reagents for six molecular forms of human chorionic gonadotropin. Clin. Chem. 51 (2005) 177-182
6. Cole L.A., and Kardana A. Discordant results in human chorionic gonadotropin assays. Clin. Chem. 38 (1992) 26-33
7. Cole L.A., Shahabi S., Oz U.A., Bahado-Singh R.O., and Mahoney M.J. Hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen) immunoassay: a new basis for gestational Down syndrome screening. Clin. Chem. 45 (1999) 2109-2119
8. Cole L.A., Sutton J.M., Higgins T.N., and Cembrowski G.S. Between-method variation in human chorionic gonadotropin test results. Clin. Chem. 50 (2004) 874-882
9. Ekins R. Measurement of free hormones in blood. Endocrine Rev. 11 (1990) 5-46
10. Fleisher M., Dnistrian A.M., Sturgeon C.M., Lamerz R., and Witliff J.L. Practice guidelines and recommendations for use of tumor markers in the clinic. Chapter 5. In: Diamandis E.P., Fritsche H.A., Lilja H., Chan D.W., and Schwartz M.K. (Eds). Tumor Markers: Physiology, Pathobiology, Technology and Clinical Applications (2002), AACC Press, Chicago 33-63
11. Kricka L. Human anti-animal antibody interferences in immunological assays. Clin. Chem. 45 (1999) 942-956
12. Lambert A., Talbot J.A., Anobile C.J., and Robertson W.R. Gonadotrophin heterogeneity and biopotency: implications for assisted reproduction. Molec. Human. Reprod. 4 (1998) 619-629
13. Nilsson C., Pettersson K., Millar R.P., Coerver K.A., Matzuk M.M., Huhtaniemi I.T., et al. Worldwide frequency of a common genetic variant of luteinizing hormone: an international collaborative research. Fertil. Steril. 67 (1997) 998-1004
14. Rose M.P. Follicle stimulating hormone. International standards and reference preparations for the calibration of immunoassays and bioassays. Clin. Chim. Acta 273 (1998) 103-117
15. Samejima N., Yamada S., Takada K., Sano T., Ozawa Y., Shimizu T., Usui M., and Shishiba Y. Serum α-subunit levels in patients with pituitary adenomas. Clin. Endocrinol. 54 (2001) 479-484
16. Seth J., Ellis A., and Al-Sadie R. Serum growth hormone measurements in clinical practice: an audit of performance in the UK National External Quality Assessment Scheme. Horm. Res. 51 suppl 1 (1999) 13-19
17. Seth J., Sturgeon C.M., Al-Sadie R., Hanning I., and Ellis A.R. External quality assessment of immunoassays of peptide hormones and tumour markers: principles and practice. Ann. Ist. Super. Sanita. 27 (1991) 359-364
18. In: Speroff L., Glass R.H., and Kase N.G. (Eds). Clinical Gynecologic Endocrinology and Infertility. sixth ed. (1999), Lippincott Williams & Wilkins, Baltimore 86-89
19. Stenman U.-H. Immunoassay Standardization: is it possible, who is responsible, who is capable?. Clin. Chem. 47 (2001) 815-820
20. Stenman U.-H. Standardization of assays for human chorionic gonadotropin. Clin. Chem. 50 (2004) 798-799
21. Storring P.L., and Gaines-Das R.E. The second international standard for human pituitary LH: its collaborative study by bioassays and immunoassays. J. Endocrinol. 138 (1993) 345-359
22. Storring P.L., and Gaines-Das R.E. The international standard for pituitary FSH: collaborative study of the standard and of four other purified human FSH preparations of differing molecular composition by bioassays, receptor assays and different immunoassay systems. J. Endocrinol. 123 (1989) 275-293
23. Storring P.L., Gaines-Das R.E., and Bangham D.R. International reference preparation of human chorionic gonadotrophin for immunoassay: potency estimates in various bioassay and protein binding assay systems; and international reference preparations of α and β subunits of human chorionic gonadotrophin for immunoassay. J. Endocrinol. 84 (1980) 295-310
24. Sturgeon C.M., and Seth J. Why do immunoassays for tumour markers give differing results? A view from the UK National External Quality Assessment Schemes. Eur. J. Clin. Chem. Clin. Biochem. 34 (1996) 755-759
25. Sturgeon C.M. Limitations of assay techniques for tumour markers, Chapter 4. In: Diamandis E.P., Fritsche H.A., Lilja H., Chan D.W., and Schwartz M.K. (Eds). Tumor Markers: Physiology, Pathobiology, Technology and Clinical Applications (2002), AACC Press, Chicago 65-81
26. Sturgeon C.M. Errors and pitfalls in immunoassay. CPD Bull. Clin. Biochem. 4 (2002) 45-55
27. Summers J., Raggatt P., Pratt J., and Williams M.V. Experience of discordant beta hCG results by different assays in the management of non-seminomatous germ cell tumours of the testis. Clin. Oncol. (R. Coll. Radiol.) 11 (1999) 388-392
28. Taylor A.E., Khoury R.H., and Crowley W.F. A comparison of 13 different immunometric assay kits for gonadotropins: implications for clinical investigation. J. Clin. Endocrinol. Metab. 79 (1994) 240-247
29. World Health Organization, 2004. 51st meeting of WHO Expert Committee on Biological Standardization. November 2001. WHO Technical Report Series.
30. WHO Expert Committee on Biological Standardization 1997: Proposed WHO International Standard for Follicle Stimulating Hormone, for Immunoassay, 92/510. WHO Technical Report Series.
31. WHO Expert Committee on Biological Standardization 1995. Proposed WHO International Standard for Follicle Stimulating Hormone, for Bioassay, 92/642. WHO Technical Report Series.
32. WHO Expert Committee on Biological Standardization 2003. Proposed WHO International Standard for Luteinizing Hormone, for Bioassay, 96/602. WHO Technical Report Series.